Defendant
3 cases as defendant.
Olympus America Inc. is the U.S. head-office and medical-equipment sales entity of Olympus Corporation of the Americas, a wholly owned subsidiary of Tokyo-based Olympus Corporation (TSE: 7733; founded 1919). Its address is 3500 Corporate Parkway, Center Valley, Pennsylvania. Olympus Corporation of the Americas states it employs more than 4,500 people across North and South America (olympusamerica.com); the global parent reported revenue of ¥936.2 billion and roughly 28,800–29,300 employees for the fiscal year ended March 31, 2024 (Olympus annual securities report; third-party profiles). No separate revenue figure for Olympus America Inc. is publicly disclosed.
Operations. The parent is a medical technology company built on endoscopy. Its Endoscopic Solutions business sells gastrointestinal and surgical endoscopes; its Therapeutic Solutions business sells GI treatment instruments, urology, respiratory, energy, otolaryngology and gynecology devices. Olympus divested non-medical lines: the consumer camera business went to Japan Industrial Partners in 2021, and the Scientific Solutions business (biological/industrial microscopes, industrial videoscopes, non-destructive testing) was transferred to Bain Capital in April 2023 as Evident Corporation (Olympus/Bain press releases).
Litigation posture. In the tracked data Olympus America is a two-way litigant in a single 2018 dispute: defendant in two consolidated Delaware actions and plaintiff in one. This reflects an operating company that counter-punched rather than a volume filer or an NPE. All three cases sit in the District of Delaware — not a plaintiff-friendly Texas venue — and all involve the same counterparty.
Notable cases. Maxell, Ltd. (formerly Hitachi Maxell, an operating media/battery company that also runs an active patent-licensing program) sued Olympus Corporation and Olympus America in D. Del. on Feb. 23, 2018 (No. 1:18-cv-00310), asserting camera-imaging patents against Olympus digital camera models (OM-D E-M1 Mark II, Pen-F, Tough TG, Air A01). Olympus had already filed a declaratory-judgment action (No. 1:18-cv-00216) on Feb. 6, 2018 and petitioned for IPR of related Maxell patents. Maxell counterclaimed on ten patents, including the '102 patent; in November 2018 the court denied Olympus's §101 motion on that patent. Outcomes beyond those rulings are not reflected in the tracked data.
Companion infringement action to Olympus's declaratory judgment case; Maxell accused Olympus of infringing the '209 Patent. The cases were treated as associated (same judges, parties, and accused products) and resolved as part of the same 2018 settlement.
Maxell, Ltd. filed an infringement action against Olympus Corporation and Olympus America Inc. in the District of Delaware. The action was related to and consolidated for discovery/Markman with the Olympus declaratory-judgment action, No. 1:18-cv-00216. The outcome was not confirmed in the retrieved sources.
IV sued Canon and originally Olympus entities; Olympus was dismissed with prejudice on Dec. 11, 2012. Jury verdicts in 2014 went for Canon on induced infringement of claims 19 and 20 of the '960 patent and for IV on '081 claim 3 and '686 claims 14 & 16. The court later found the '960 claims anticipated and granted IV a new trial on infringement of the '348 and '960 patents; a subsequent ruling found a claim 1 limitation indefinite. No final liability win on the '960 patent for IV against Canon.